{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:22:23Z","timestamp":1778682143088,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AstraZeneca do Brasil","award":["ESR-14-10627"],"award-info":[{"award-number":["ESR-14-10627"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304257\/2021-4"],"award-info":[{"award-number":["304257\/2021-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03142-y","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:30:12Z","timestamp":1774521012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Sheila T.","family":"Kimura-Medorima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela C","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikaro","family":"Breder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaneza Lira W.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre A.S.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Bonilha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Sergio F.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio R.","family":"Coelho-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto","family":"Matos-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipe A.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Nadruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago","family":"Quinaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei C.","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"3142_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/A:1026563313952","volume":"5","author":"TC Gillebert","year":"2000","unstructured":"Gillebert TC, Leite-Moreira AF, De Hert SG. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev. 2000;5:345\u201355.","journal-title":"Heart Fail Rev"},{"key":"3142_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0008-6363(99)00099-1","volume":"43","author":"AF Leite-Moreira","year":"1999","unstructured":"Leite-Moreira AF, Correia-Pinto J, Gillebert TC. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res. 1999;43:344\u201353.","journal-title":"Cardiovasc Res"},{"key":"3142_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-021-01314-6","volume":"20","author":"L Nesti","year":"2021","unstructured":"Nesti L, Pugliese NR, Sciuto P, De Biase N, Mazzola M, Fabiani I, Trico D, Masi S, Natali A. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes. Cardiovasc Diabetol. 2021;20:124.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR4","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:e263\u2013421.","journal-title":"J Am Coll Cardiol"},{"key":"3142_CR5","doi-asserted-by":"crossref","unstructured":"Durante W, Behnammanesh G, Peyton KJ. Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22168786"},{"key":"3142_CR6","doi-asserted-by":"publisher","first-page":"851941","DOI":"10.3389\/fendo.2022.851941","volume":"13","author":"M Wang","year":"2022","unstructured":"Wang M, Li Y, Li S, Lv J. Endothelial Dysfunction and Diabetic Cardiomyopathy. Front Endocrinol (Lausanne). 2022;13:851941.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3142_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"3142_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","volume":"60","author":"CN Marti","year":"2012","unstructured":"Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60:1455\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"3142_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, Bohm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukat A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjostrand M, Langkilde AM. Committees D-HT and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381:1995\u20132008.","journal-title":"N Engl J Med"},{"key":"3142_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pina IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M. Investigators EM-PT. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451\u201361.","journal-title":"N Engl J Med"},{"key":"3142_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, De Boer RA, Demets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, Belohlavek J, Chiang C-E, Borleffs CJW, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer-Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O\u2019Meara E, Saraiva JFK, Tereshchenko SN, Thierer J, Vaduganathan M, Vardeny O, Verma S, Pham VN, Wilder\u00e4ng U, Zaozerska N, Bachus E, Lindholm D, Petersson M, Langkilde AM. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022;387:1089\u201398.","journal-title":"N Engl J Med"},{"key":"3142_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S. Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC Basic Transl Sci. 2020;5:632\u201344.","journal-title":"JACC Basic Transl Sci"},{"key":"3142_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2018.01.032","volume":"197","author":"H Li","year":"2018","unstructured":"Li H, Shin SE, Seo MS, An JR, Choi IW, Jung WK, Firth AL, Lee DS, Yim MJ, Choi G, Lee JM, Na SH, Park WS. The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels. Life Sci. 2018;197:46\u201355.","journal-title":"Life Sci"},{"key":"3142_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/ehjcvp\/pvad053","volume":"9","author":"K Dimitriadis","year":"2023","unstructured":"Dimitriadis K, Adamopoulou E, Pyrpyris N, Sakalidis A, Leontsinis I, Manta E, Mantzouranis E, Beneki E, Soulaidopoulos S, Konstantinidis D, Fragkoulis C, Aggeli K, Tsioufis K. The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyond. Eur Heart J Cardiovasc Pharmacother. 2023;9:741\u201357.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"3142_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-022-01607-4","volume":"21","author":"L Leccisotti","year":"2022","unstructured":"Leccisotti L, Cinti F, Sorice GP, D\u2019Amario D, Lorusso M, Guzzardi MA, Mezza T, Gugliandolo S, Cocchi C, Capece U, Indovina L, Ferraro PM, Iozzo P, Crea F, Giordano A, Giaccari A. Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report. Cardiovasc Diabetol. 2022;21:173.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.124.068788","volume":"150","author":"A Tada","year":"2024","unstructured":"Tada A, Burkhoff D, Naser JA, Harada T, Pourmussa B, Reddy YNV, Jensen MD, Carter RE, Demmer RT, Testani JM, Chirinos JA, Borlaug BA. Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Circulation. 2024;150:997\u20131009.","journal-title":"Circulation"},{"key":"3142_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/dom.12572","volume":"17","author":"R Chilton","year":"2015","unstructured":"Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metab. 2015;17:1180\u201393.","journal-title":"Diabetes Obes Metab"},{"key":"3142_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","volume":"18","author":"DD Adingupu","year":"2019","unstructured":"Adingupu DD, Gopel SO, Gronros J, Behrendt M, Sotak M, Miliotis T, Dahlqvist U, Gan LM, Jonsson-Rylander AC. SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob(-\/-) mice. Cardiovasc Diabetol. 2019;18:16.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR19","doi-asserted-by":"crossref","unstructured":"Choi S, Haam CE, Byeon S, Oh EY, Choi SK, Lee YH. Investigating the Cardiovascular Benefits of Dapagliflozin: Vasodilatory Effect on Isolated Rat Coronary Arteries. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms242316873"},{"key":"3142_CR20","doi-asserted-by":"crossref","unstructured":"Soga F, Tanaka H, Tatsumi K, Mochizuki Y, Sano H, Toki H, Matsumoto K, Shite J, Takaoka H, Doi T, Hirata K-I. Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure. Cardiovasc Diabetol. 2018;17.","DOI":"10.1186\/s12933-018-0775-z"},{"key":"3142_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13098-019-0457-3","volume":"11","author":"RMR Cintra","year":"2019","unstructured":"Cintra RMR, Soares AAS, Breder I, Munhoz DB, Barreto J, Kimura-Medorima ST, Cavalcante P, Zanchetta R, Breder JC, Moreira C, Virginio VW, Bonilha I, Lima-Junior JC, Coelho-Filho OR, Wolf VLW, Guerra-Junior G, Oliveira DC, Haeitmann R, Fernandes VHR, Nadruz W, Chaves FRP, Arieta CEL, Quinaglia T. Sposito AC and investigators A-Bt. Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial. Diabetol Metab Syndr. 2019;11:62.","journal-title":"Diabetol Metab Syndr"},{"key":"3142_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BAA, Simple. Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138:861\u201370.","journal-title":"Circulation"},{"key":"3142_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1\u2013e3914.","journal-title":"J Am Soc Echocardiogr"},{"key":"3142_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","volume":"17","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD, Houston T, Oslo N, Phoenix A, Nashville T, Hamilton O, Canada, Uppsala S, Ghent, Li\u00e8ge B, Cleveland O, Novara I, Rochester M, Bucharest R. and and St. Louis Ms. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321\u201360.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3142_CR25","doi-asserted-by":"publisher","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","volume":"300","author":"DH Thijssen","year":"2011","unstructured":"Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2\u201312.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3142_CR26","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"Thijssen DHJ, Bruno RM, van Mil A, Holder SM, Faita F, Greyling A, Zock PL, Taddei S, Deanfield JE, Luscher T, Green DJ, Ghiadoni L. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40:2534\u201347.","journal-title":"Eur Heart J"},{"key":"3142_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-021-01264-z","volume":"20","author":"AC Sposito","year":"2021","unstructured":"Sposito AC, Breder I, Soares AAS, Kimura-Medorima ST, Munhoz DB, Cintra RMR, Bonilha I, Oliveira DC, Breder JC, Cavalcante P, Moreira C, Moura FA, de Lima-Junior JC, do Carmo HRP, Barreto J, Nadruz W, Carvalho LSF. Quinaglia T and investigators A-Bt. Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial. Cardiovasc Diabetol. 2021;20:74.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1148\/radiology.211.2.r99ma48411","volume":"211","author":"RO Bude","year":"1999","unstructured":"Bude RO, Rubin JM. Relationship between the resistive index and vascular compliance and resistance. Radiology. 1999;211:411\u20137.","journal-title":"Radiology"},{"key":"3142_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7863\/jum.1990.9.8.449","volume":"9","author":"J Legarth","year":"1990","unstructured":"Legarth J, Nolsoe C. Doppler blood velocity waveforms and the relation to peripheral resistance in the brachial artery. J Ultrasound Med. 1990;9:449\u201353.","journal-title":"J Ultrasound Med"},{"key":"3142_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/0735-1097(92)90617-V","volume":"19","author":"A Ganau","year":"1992","unstructured":"Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"3142_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2023.04.010","volume":"374","author":"H Holm","year":"2023","unstructured":"Holm H, Magnusson M, Jujic A, Pugliese NR, Bozec E, Lamiral Z, Huttin O, Zannad F, Rossignol P, Girerd N. Ventricular-arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort. Atherosclerosis. 2023;374:11\u201320.","journal-title":"Atherosclerosis"},{"key":"3142_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"3142_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ehjci\/jeae018","volume":"25","author":"M Yafasov","year":"2024","unstructured":"Yafasov M, Olsen FJ, Skaarup KG, Lassen MCH, Johansen ND, Lindgren FL, Jensen GB, Schnohr P, M\u00f8gelvang R. S\u00f8gaard P and Biering-S\u00f8rensen T. Normal values for left atrial strain, volume, and function derived from 3D echocardiography: the Copenhagen City Heart Study. Eur Heart J Cardiovasc Imaging. 2024;25:602\u201312.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3142_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12933-022-01618-1","volume":"21","author":"L Nesti","year":"2022","unstructured":"Nesti L, Pugliese NR, Sciuto P, Trico D, Dardano A, Baldi S, Pinnola S, Fabiani I, Di Bello V, Natali A. Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial. Cardiovasc Diabetol. 2022;21:181.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jcmg.2020.07.042","volume":"14","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Garcia-Ropero A, Ishikawa K, Watanabe S, Picatoste B, Vargas-Delgado AP, Flores-Umanzor EJ, Sanz J, Fuster V, Badimon JJ. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis\/Stiffness in Nondiabetic Heart Failure: A Multimodality Study. JACC Cardiovasc Imaging. 2021;14:393\u2013407.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3142_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","volume":"4","author":"RP Juni","year":"2019","unstructured":"Juni RP, Kuster DWD, Goebel M, Helmes M, Musters RJP, van der Velden J, Koolwijk P, Paulus WJ, van Hinsbergh VWM. Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin. JACC Basic Transl Sci. 2019;4:575\u201391.","journal-title":"JACC Basic Transl Sci"},{"key":"3142_CR37","doi-asserted-by":"publisher","first-page":"606740","DOI":"10.3389\/fphys.2020.606740","volume":"11","author":"HE Boycott","year":"2020","unstructured":"Boycott HE, Nguyen MN, Vrellaku B, Gehmlich K, Robinson P. Nitric Oxide and Mechano-Electrical Transduction in Cardiomyocytes. Front Physiol. 2020;11:606740.","journal-title":"Front Physiol"},{"key":"3142_CR38","doi-asserted-by":"publisher","first-page":"e3215","DOI":"10.1002\/dmrr.3215","volume":"36","author":"A Villano","year":"2020","unstructured":"Villano A, Mencarelli E, Melita V, Rizzi A, Lamendola P, De Vita A, Manfredonia L, Ravenna SE, Pitocco D, Lanza GA, Crea F. Endothelial dysfunction and cardiovascular outcome in asymptomatic patients with type 2 diabetes: A pilot study. Diabetes Metab Res Rev. 2020;36:e3215.","journal-title":"Diabetes Metab Res Rev"},{"key":"3142_CR39","first-page":"100584","volume":"30","author":"R Taher","year":"2020","unstructured":"Taher R, Sara JD, Toya T, Borlaug BA, Lerman LO, Lerman A. Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression. Int J Cardiol Heart Vasc. 2020;30:100584.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"3142_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11010-019-03555-2","volume":"459","author":"S Cooper","year":"2019","unstructured":"Cooper S, Teoh H, Campeau MA, Verma S, Leask RL. Empagliflozin restores the integrity of the endothelial glycocalyx in vitro. Mol Cell Biochem. 2019;459:121\u201330.","journal-title":"Mol Cell Biochem"},{"key":"3142_CR41","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1210\/jc.2019-00706","volume":"104","author":"A Solini","year":"2019","unstructured":"Solini A, Seghieri M, Giannini L, Biancalana E, Parolini F, Rossi C, Dardano A, Taddei S, Ghiadoni L, Bruno RM. The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature. J Clin Endocrinol Metab. 2019;104:4253\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"3142_CR42","doi-asserted-by":"crossref","unstructured":"Venkatesan S, Smirne C, Aquino CI, Surico D, Remorgida V, Ola Pour MM, Pirisi M, Grossini E. Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers. Int J Mol Sci. 2026;27.","DOI":"10.3390\/ijms27020629"},{"key":"3142_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0025-6196(25)05396-0","volume":"45","author":"BC Campion","year":"1970","unstructured":"Campion BC, Frye RL, Zitnik RS. Effects of nitroglycerin on capacitance vessels: a mechanism for reduction of left ventricular end-diastolic pressure. Mayo Clin Proc. 1970;45:573\u20138.","journal-title":"Mayo Clin Proc"},{"key":"3142_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/01.CIR.101.2.165","volume":"101","author":"DJ Blackman","year":"2000","unstructured":"Blackman DJ, Morris-Thurgood JA, Atherton JJ, Ellis GR, Anderson RA, Cockcroft JR, Frenneaux MP. Endothelium-derived nitric oxide contributes to the regulation of venous tone in humans. Circulation. 2000;101:165\u201370.","journal-title":"Circulation"},{"key":"3142_CR45","doi-asserted-by":"publisher","first-page":"e009156","DOI":"10.1161\/CIRCHEARTFAILURE.121.009156","volume":"15","author":"M Omar","year":"2022","unstructured":"Omar M, Jensen J, Burkhoff D, Frederiksen PH, Kistorp C, Videbaek L, Poulsen MK, Gustafsson F, Kober L, Borlaug BA, Schou M, Moller JE. Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial. Circ Heart Fail. 2022;15:e009156.","journal-title":"Circ Heart Fail"},{"key":"3142_CR46","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.111.177469","volume":"58","author":"J Hashimoto","year":"2011","unstructured":"Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58:839\u201346.","journal-title":"Hypertension"},{"key":"3142_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.medcli.2019.05.028","volume":"154","author":"JC Hidalgo Santiago","year":"2020","unstructured":"Hidalgo Santiago JC, Maraver Delgado J, Cayon Blanco M, Lopez Saez JB, Gomez-Fernandez P. Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus. Med Clin (Barc). 2020;154:171\u20134.","journal-title":"Med Clin (Barc)"},{"key":"3142_CR48","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jcmg.2022.03.024","volume":"15","author":"NR Pugliese","year":"2022","unstructured":"Pugliese NR, Balletti A, Armenia S, De Biase N, Faita F, Mengozzi A, Paneni F, Ruschitzka F, Virdis A, Ghiadoni L, Taddei S, Williams B, Antonini-Canterin F, Masi S. Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure Spectrum. JACC Cardiovasc Imaging. 2022;15:1545\u201359.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3142_CR49","doi-asserted-by":"publisher","first-page":"e09503","DOI":"10.1016\/j.heliyon.2022.e09503","volume":"8","author":"A Hasan","year":"2022","unstructured":"Hasan A, Menon SN, Zerin F, Hasan R. Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell K(V)7 ion channels. Heliyon. 2022;8:e09503.","journal-title":"Heliyon"},{"key":"3142_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-019-0876-3","volume":"18","author":"J Bogdanovic","year":"2019","unstructured":"Bogdanovic J, Asanin M, Krljanac G, Lalic NM, Jotic A, Stankovic S, Rajkovic N, Stosic L, Rasulic I, Milin J, Popovic D, Bogdanovic L, Lalic K. Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography. Cardiovasc Diabetol. 2019;18:68.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12933-016-0452-z","volume":"15","author":"J Xie","year":"2016","unstructured":"Xie J, Cui K, Hao H, Zhang Y, Lin H, Chen Z, Huang X, Cao S, Liao W, Bin J, Kitakaze M, Liao Y. Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulation. Cardiovasc Diabetol. 2016;15:136.","journal-title":"Cardiovasc Diabetol"},{"key":"3142_CR52","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1152\/japplphysiol.90600.2008","volume":"105","author":"PD Chantler","year":"2008","unstructured":"Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol (1985). 2008;105:1342\u201351.","journal-title":"J Appl Physiol (1985)"},{"key":"3142_CR53","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S2213-8587(18)30233-X","volume":"6","author":"CK Chow","year":"2018","unstructured":"Chow CK, Ramasundarahettige C, Hu W, AlHabib KF, Avezum A Jr., Cheng X, Chifamba J, Dagenais G, Dans A, Egbujie BA, Gupta R, Iqbal R, Ismail N, Keskinler MV, Khatib R, Kruger L, Kumar R, Lanas F, Lear S, Lopez-Jaramillo P, McKee M, Mohammadifard N, Mohan V, Mony P, Orlandini A, Rosengren A, Vijayakumar K, Wei L, Yeates K, Yusoff K, Yusuf R, Yusufali A, Zatonska K, Zhou Y, Islam S, Corsi D, Rangarajan S, Teo K, Gerstein HC. Yusuf S and investigators P. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. Lancet Diabetes Endocrinol. 2018;6:798\u2013808.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3142_CR54","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ahj.2011.07.030","volume":"162","author":"D Castagno","year":"2011","unstructured":"Castagno D, Baird-Gunning J, Jhund PS, Biondi-Zoccai G, MacDonald MR, Petrie MC, Gaita F, McMurray JJ. Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J. 2011;162:938\u201348. e2.","journal-title":"Am Heart J"},{"key":"3142_CR55","doi-asserted-by":"publisher","first-page":"177035","DOI":"10.1016\/j.ejphar.2024.177035","volume":"984","author":"ECRG Miranda","year":"2024","unstructured":"Miranda ECRG, Bruno AS, Pereira CA, Bello FLM, Rodrigues YB, Silva MG, Bernardes SS, MGM EC, Ferreira AJ, Tostes RC, Cau S. Glibenclamide reverses cardiac damage and NLRP3 inflammasome activation associated with a high refined sugar diet. Eur J Pharmacol. 2024;984:177035.","journal-title":"Eur J Pharmacol"},{"key":"3142_CR56","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"3142_CR57","doi-asserted-by":"publisher","first-page":"e000223","DOI":"10.1136\/bmjdrc-2016-000223","volume":"4","author":"T Inoue","year":"2016","unstructured":"Inoue T, Maeda Y, Sonoda N, Sasaki S, Kabemura T, Kobayashi K, Inoguchi T. Hyperinsulinemia and sulfonylurea use are independently associated with left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus with suboptimal blood glucose control. BMJ Open Diabetes Res Care. 2016;4:e000223.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3142_CR58","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2337\/dc18-1569","volume":"42","author":"A Latva-Rasku","year":"2019","unstructured":"Latva-Rasku A, Honka MJ, Kullberg J, Mononen N, Lehtimaki T, Saltevo J, Kirjavainen AK, Saunavaara V, Iozzo P, Johansson L, Oscarsson J, Hannukainen JC, Nuutila P. The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients. Diabetes Care. 2019;42:931\u20137.","journal-title":"Diabetes Care"},{"key":"3142_CR59","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.diabet.2021.101304","volume":"48","author":"I Breder","year":"2022","unstructured":"Breder I, Wolf VLW, Soares AAS, de Carvalho LSF, Kimura-Medorima ST, Cintra RM, Barreto J, Munhoz DB, Cunha JS, Bonilha I, Coelho-Filho OR, Quinaglia T, Nadruz W, Guerra-Junior G, Muscelli E. Sposito AC and Investigators A-BT. Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial. Diabetes Metab. 2022;48:101304.","journal-title":"Diabetes Metab"},{"key":"3142_CR60","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1159\/000481638","volume":"43","author":"B Salani","year":"2017","unstructured":"Salani B, Ravera S, Fabbi P, Garibaldi S, Passalacqua M, Brunelli C, Maggi D, Cordera R. and Ameri P. Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells. Cell Physiol Biochem. 2017;43:879\u201390.","journal-title":"Cell Physiol Biochem"},{"key":"3142_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.104.074369","volume":"312","author":"SY Lee","year":"2005","unstructured":"Lee SY, Lee CO. Inhibition of Na+-K+ pump and L-type Ca2\u2009+\u2009channel by glibenclamide in Guinea pig ventricular myocytes. J Pharmacol Exp Ther. 2005;312:61\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"3142_CR62","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1210\/clinem\/dgab834","volume":"107","author":"FH Shi","year":"2022","unstructured":"Shi FH, Li H, Shen L, Xu L, Ge H, Gu ZC, Lin HW, Pu J. Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function. J Clin Endocrinol Metab. 2022;107:1191\u2013203.","journal-title":"J Clin Endocrinol Metab"},{"key":"3142_CR63","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jacc.2024.02.020","volume":"83","author":"A Marton","year":"2024","unstructured":"Marton A, Saffari SE, Rauh M, Sun RN, Nagel AM, Linz P, Lim TT, Takase-Minegishi K, Pajarillaga A, Saw S, Morisawa N, Yam WK, Minegishi S, Totman JJ, Teo S, Teo LLY, Ng CT, Kitada K, Wild J, Kovalik JP, Luft FC, Greasley PJ, Chin CWL. Sim DKL and Titze J. Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure. J Am Coll Cardiol. 2024;83:1386\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"3142_CR64","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12933-020-01191-5","volume":"19","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Node K. How should we monitor the cardiovascular benefit of sodium-glucose cotransporter 2 inhibition? Cardiovasc Diabetol. 2020;19:206.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03142-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:03:48Z","timestamp":1778681028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03142-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3142"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03142-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research group includes five female investigators, including the first and second authors. Besides physicians, a nurse, a physiotherapist and a biomedical scientist contributed to the execution of this clinical trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Diversity information"}}],"article-number":"140"}}